Jaguar Health (NASDAQ:JAGX) Shares Pass Above 50-Day Moving Average – Time to Sell?

Shares of Jaguar Health, Inc. (NASDAQ:JAGX) passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $1.02 and traded as high as $1.20. Jaguar Health shares last traded at $1.09, with a volume of 425,377 shares changing hands.

Analyst Ratings Changes

Separately, StockNews.com upgraded Jaguar Health from a “sell” rating to a “hold” rating in a research note on Friday, September 13th.

Jaguar Health Trading Down 8.3 %

The company has a debt-to-equity ratio of 1.65, a current ratio of 1.84 and a quick ratio of 1.36. The stock’s fifty day moving average price is $1.02 and its two-hundred day moving average price is $1.52.

Institutional Investors Weigh In On Jaguar Health

An institutional investor recently bought a new position in Jaguar Health stock. Virtu Financial LLC purchased a new stake in Jaguar Health, Inc. (NASDAQ:JAGX) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 25,591 shares of the biotechnology company’s stock, valued at approximately $35,000. Virtu Financial LLC owned about 0.22% of Jaguar Health at the end of the most recent reporting period. Hedge funds and other institutional investors own 12.04% of the company’s stock.

Jaguar Health Company Profile

Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.